BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
UFCS
United Fire Group, Inc.
UFCS has the edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
UFCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
UFCS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like UFCS.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
UFCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.9x | $46.41 | -9.5% |
| Current | 9.8x | $51.30 | — |
| Fair | 11x | $59.07 | +15% |
| Forward | 11x | $51.30 | — |
| Expensive | 44x | $229 | +347% |
Historical ranges are pointers, not guarantees.
UFCS has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over UFCS on the outlook, with more favorable valuation and profitability expectations.
UFCS Forward outlook
| Metric | Outlook |
|---|---|
| Deteriorating | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for UFCS, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
UFCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.63 | -11% |
| Q3 2026 | $5.23 | +23% |
| Q2 2026 | $5.38 | +53% |
| Q1 2026 | $4.96 | +95% |
| Q4 2025 | $4.48 | +87% |
| Q3 2025 | $4.25 | +119% |
| Q2 2025 | $3.52 | +146% |
| Q1 2025 | $2.54 | +$3.23 |
| Q4 2024 | $2.39 | +$3.57 |
UFCS's earnings per share have climbed steadily: $5.23 over the past year, up 23% from the year before, and higher year over year for 10 quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over UFCS on profitability, with a higher operating margin.
UFCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $391.6M | +11% |
| Q2 2026 | $383.7M | +14% |
| Q1 2026 | $369.4M | +12% |
| Q4 2025 | $365.8M | +9.8% |
| Q3 2025 | $354M | +9.6% |
| Q2 2025 | $335.5M | +11% |
| Q1 2025 | $331.1M | +12% |
| Q4 2024 | $333.2M | +16% |
UFCS has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 11% | -2.3 points |
| Q2 2026 | 11% | +2.2 points |
| Q1 2026 | 10% | +3.7 points |
| Q4 2025 | 13% | +1.3 points |
| Q3 2025 | 14% | +6 points |
| Q2 2025 | 8.7% | +9.9 points |
| Q1 2025 | 6.6% | +1.1 points |
| Q4 2024 | 12% | +3.5 points |
UFCS's operating margin was 11% last quarter, down 2.3 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
UFCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $101.1M | +66% |
| Q2 2026 | $34.2M | -36% |
| Q1 2026 | $56.6M | +59% |
| Q4 2025 | $119.8M | -23% |
| Q3 2025 | $60.8M | +7.8% |
| Q2 2025 | $53.4M | -42% |
| Q1 2025 | $35.7M | -1.3% |
| Q4 2024 | $156.4M | +603% |
UFCS's free cash flow was $312M over the past year, up 1.8% from the year before. Free cash flow isn't a meaningful measure for financial services companies like UFCS.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over UFCS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
UFCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +271K shares |
| 1 year | -0.8% | -201K shares |
| 3 years | +2.3% | +587K shares |
| 5 years | +4.3% | +1.1M shares |
| Available history | +2.3% | +584K shares |
UFCS has 26M diluted shares, down 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | $1,000 |
| Q3 2021 | $1M |
| Q2 2021 | $1M |
| Q1 2021 | $7,000 |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
UFCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.0x | Net Cash |
| Q2 2026 | 0.0x | Very low |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.6x | Net Cash |
| Q2 2025 | -1.6x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
UFCS has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
UFCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 44.4 | Neutral |
UFCS's weekly RSI is 51 (neutral) and its Stochastic is 44 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
UFCS PE vs Financial Services Sector
| Metric | UFCS | Sector median | Relative |
|---|---|---|---|
| PE | 9.8x | 13x | 25% below |
| PE % | 31 | 63 | 32 pts below |
UFCS has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
UFCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $54.1 | 5.2% below |
| 20 week MA | $53.7 | 4.4% below |
| 50 week MA | $45.5 | 13% above |
| 100 week MA | $37.3 | 38% above |
| 200 week MA | $30.1 | 71% above |
UFCS has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
UFCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.2 | $24.5 | -43% |
| 2021 | $24.5 | $23.3 | -4.9% |
| 2022 | $23.3 | $28.4 | +22% |
| 2023 | $28.4 | $20.1 | -29% |
| 2024 | $20.1 | $28.5 | +42% |
| 2025 | $28.5 | $36.4 | +28% |
| 2026 YTD | $36.4 | $51.3 | +41% |
UFCS has the edge over BAC on returns for 2026, with the stronger performance.